| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902991 | Metabolism | 2016 | 55 Pages |
Abstract
In this narrative review, the associations between NAFLD, dyslipidemia and vascular disease in NAFLD patients are discussed. NAFLD treatment is also reviewed with a focus on lipid-lowering drugs. Finally, future perspectives in terms of both NAFLD diagnostic biomarkers and therapeutic targets are considered.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros,